March 19, 2026
SOHO Insider Hem/Onc Library Leukemia Chronic Myeloid Leukemia
SOHO 2026
SOHO 2026 SOHO Asia 2026 Trending now Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms Society Updates

Registration now open for SOHO 2026, receive early bird rates until June 10

Leukemia Chronic Myeloid Leukemia Myelodysplastic Syndromes News

Pathways & Perspectives with Valeria Santini, MD

Leukemia Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia News

US launch of tyrosine kinase inhibitor in Ph+ CML, ALL

Leukemia Chronic Myeloid Leukemia

Generic version of nilotinib enters US market for treatment of certain leukemias

person spraying weeds
Leukemia Chronic Myeloid Leukemia News

Making resistance futile: lessons from the fields

A close up of a globe with a network of lines surrounding it. Concept of interconnectedness and the vastness of the world
Leukemia Chronic Myeloid Leukemia

‘Remarkable’ tolerability observed with asciminib in a heavily pretreated real-world CML-CP population

CML
Leukemia Chronic Myeloid Leukemia

IND approved in Korea for CML treatment KF1601

Leukemia cells and red blood cells
Leukemia Chronic Myeloid Leukemia News

Dasatinib, asciminib combo shows ‘promise’ for upfront treatment of Ph+ ALL

Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Roundtable Discussions

Drs. Kantarjian, Litzow Discuss Blinatumomab Breakthrough in E1910 Trial

Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia

Is Blinatumomab Plus Chemotherapy in MRD-Negative BCP-ALL Superior to Chemotherapy-alone?